- Home
- CNTB vs NUKK Comparison
CNTB vs NUKK Comparison
Compare CNTB & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- NUKK
- Stock Information
- Founded
- CNTB 2012
- NUKK 2013
- Country
- CNTB United States
- NUKK United States
- Employees
- CNTB N/A
- NUKK N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- NUKK Blank Checks
- Sector
- CNTB Health Care
- NUKK Finance
- Exchange
- CNTB Nasdaq
- NUKK Nasdaq
- Market Cap
- CNTB 94.2M
- NUKK 100.0M
- IPO Year
- CNTB 2021
- NUKK N/A
- Fundamental
- Price
- CNTB $1.59
- NUKK $7.12
- Analyst Decision
- CNTB Strong Buy
- NUKK
- Analyst Count
- CNTB 2
- NUKK 0
- Target Price
- CNTB $7.50
- NUKK N/A
- AVG Volume (30 Days)
- CNTB 79.5K
- NUKK 2.6M
- Earning Date
- CNTB 11-30-2025
- NUKK 11-14-2025
- Dividend Yield
- CNTB N/A
- NUKK N/A
- EPS Growth
- CNTB N/A
- NUKK N/A
- EPS
- CNTB N/A
- NUKK N/A
- Revenue
- CNTB $1,965,000.00
- NUKK N/A
- Revenue This Year
- CNTB N/A
- NUKK N/A
- Revenue Next Year
- CNTB $453,067.90
- NUKK N/A
- P/E Ratio
- CNTB N/A
- NUKK N/A
- Revenue Growth
- CNTB N/A
- NUKK N/A
- 52 Week Low
- CNTB $1.23
- NUKK $1.30
- 52 Week High
- CNTB $2.20
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- CNTB 45.14
- NUKK 45.16
- Support Level
- CNTB $1.50
- NUKK $6.71
- Resistance Level
- CNTB $1.72
- NUKK $8.70
- Average True Range (ATR)
- CNTB 0.13
- NUKK 1.81
- MACD
- CNTB -0.02
- NUKK -0.46
- Stochastic Oscillator
- CNTB 18.00
- NUKK 5.41
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).